Castle Biosciences, Inc.CSTLNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank38
3Y CAGR+71.7%
5Y CAGR-49.6%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+71.7%/yr
vs -70.6%/yr prior
5Y CAGR
-49.6%/yr
Recent acceleration
Acceleration
+142.3pp
Accelerating
Percentile
P38
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $86000.00 | -85.1% |
| 2024 | $577000.00 | +5145.5% |
| 2023 | $11000.00 | -35.3% |
| 2022 | $17000.00 | +1600.0% |
| 2021 | $1000.00 | -100.0% |
| 2020 | $2.63M | -42.4% |
| 2019 | $4.57M | +101.0% |
| 2018 | $2.27M | +37.8% |
| 2017 | $1.65M | - |